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The vast majority of patients suffering from a primary immunodeﬁciency (PID) have defects
in their T- and/or B-cell compartments. Despite advances in molecular diagnostics, in
many patients no underlying genetic defect has been identiﬁed. B- and T-lymphocytes
are unique in their ability to create a receptor by genomic rearrangement of their anti-
gen receptor genes via V(D)J recombination. During this process, stable circular excision
products are formed that do not replicate when the cell proliferates. Excision circles
can be reliably quantiﬁed using real-time quantitative (RQ-)PCR techniques. Frequently
occurring δREC–ψJα T-cell receptor excision circles (TRECs) have been used to assess
thymic output and intronRSS–Kde recombination excision circles (KREC) to quantify B-cell
replication history. In this perspective, we describe how TRECs and KRECs are formed
during precursor – T- and B-cell differentiation, respectively. Furthermore, we discuss new
insights obtained with TRECs and KRECs and speciﬁcally how these excision circles can
be applied to support therapy monitoring, patient classiﬁcation and newborn screening
of PID.
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PRIMARY IMMUNODEFICIENCIES OF THE LYMPHOID
SYSTEM
Primary immunodeﬁciencies (PID) are rare inherited disorders of
the immune system. Mutations in a single gene can affect one
or more immunological components of the individual, result-
ing in increased susceptibility to infections, often accompanied
by immunoregulatory defects (Notarangelo, 2010).
The vast majority of PID patients have impaired T- and/or B-
cell function. T- and B-cells have the ability to create a unique
receptor to recognize antigen. Furthermore, upon encounter with
their speciﬁc antigen, they generate immunological memory by
means of long-lived antigen-speciﬁc memory cells and antibody-
producing plasma cells. Thus, defects in these cells grossly impair
immunity. T-cell defects result in combined immunodeﬁciency
(CID), affecting both cellular and humoral immunity. These
patients suffer from opportunistic infections. The most severe
CID variant (SCID) is fatal in the ﬁrst months of life unless stem
cell transplantation is provided. These patients lack T-cells, often
combinedwith lackof B-cells,due to early arrests inprecursor lym-
phocyte differentiation (Figure 1). B-cell defects lead to antibody
deﬁciency. This defect in humoral immunity results in increased
susceptibility to encapsulated bacteria. A subgroup of patients has
Abbreviations: IgH, immunoglobulin heavy chain; Igκ , immunoglobulin
kappa light chain; Igλ, immunoglobulin lambda light chain; KREC, kappa-
deleting recombination excision circle; PID, primary immunodeﬁciency; RQ-
PCR, real-time quantitative PCR; TCR, T-cell receptor; TREC, T-cell receptor
excision circle.
agammaglobulinemia,due to a B-cell differentiation arrest in bone
marrow and the consequent absence of mature B-cells and serum
immunoglobulins (Figure 1). Over 30% of patients develop irre-
versible organ damage, mainly in the lungs, in childhood or early
adulthood (Quinti et al., 2007). Early treatment with intravenous
immunoglobulins and prophylactic antibiotics may prevent this
(Lucas et al., 2010).
Whereas many genetic defects have been identiﬁed
(Notarangelo et al., 2009), a molecular diagnosis has not been
made in the vast majority of patients with a primary antibody
deﬁciency (van der Burg et al., 2011). Furthermore, mild genetic
variants in known disease-causing genes can give rise to a broad
clinical spectrum of diseases (Schuetz et al., 2008; Conley et al.,
2009; IJspeert et al., 2011). Thus, new assays are required to
establish an early identiﬁcation of disease and proper diagno-
sis with estimation of future complication risks. Over the past
10 years, many studies have addressed immunological defects to
deﬁne subgroups of CID or antibody deﬁcient patients. One of
the newly explored methods involves quantiﬁcation of circular
DNA products that are generated in early lymphocyte develop-
ment during the creation of unique B- and T-cell receptors. In
this perspective, we will ﬁrst address how recombination exci-
sion circles are formed and how these products can be used to
study the mature B- and T-cell compartments. Subsequently, we
will discuss recent insights obtained by quantiﬁcation of these
excision circles and potential applications to support early diag-
nosis, classiﬁcation, therapy monitoring and newborn screening
of PID.
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FIGURE 1 | Human B- andT-cell differentiation stages including
V(D)J recombination bars (Dik et al., 2005; van Zelm et al., 2005)
and genetic defects underlying PID that result in impaired
precursor differentiation. Blocks in B-cell development are derived
from immunophenotyping studies on bone marrow samples from
agammaglobulinemia and SCID patients. Developmental blocks in the
T-cell lineage largely rely on data from targeted mutation studies in
the mouse.
V(D)J RECOMBINATION AND FORMATION OF EXCISION
CIRCLES
The gene complexes encoding the T- and B-cell receptor compo-
nents do not contain a functional ﬁrst exon. Instead, they contain
multiple variable (V), diversity (D), and joining (J) genes. Dur-
ing antigen-independent differentiation in bone marrow (B-cells)
and thymus (T-cells), stepwise rearrangements are introduced in
the genome to couple one of each segment together to form a
functional ﬁrst exon (Figure 1).
Precursor-T cells in thymus ﬁrst start to rearrange their T-cell
receptor (TCR) D and TCRG genes (Figure 1). When this leads to
a functional receptor, the cell exits the thymus as TCRγδ+ T-cell.
Most cells, however, do not form a functional γδ TcR and start
rearranging their TCRB and TCRA genes. Upon successful com-
pletion, these cells exit the thymus with an αβ TcR. In TCRD and
TCRB loci, D to J gene rearrangements are induced prior to V to
DJ rearrangements. TCRA and TCRG lack D gene segments and
directly couple a V to a J gene segment.
Precursor B-cells start withD to J gene rearrangements in the Ig
heavy chain locus (IGH), followed byV toDJ gene rearrangements
(Figure 1). Upon successful completion, Ig light chain rearrange-
ments are induced in the IGK locus, leading to direct V to J
coupling. When IGK light chain rearrangements are not success-
ful, V to J gene rearrangements are induced in the IGL light chain
locus. Thus, mature B-cells can exit the bone marrow expressing
an antigen receptor with either an Igκ or an Igλ isotype.
Double strand DNA breaks are introduced by the recombina-
tion activating gene products RAG1 and RAG2 on the borders
of two gene segments and the ﬂanking recombination signal
sequences (RSS). The resulting coding ends at the side of the gene
segments are ligated together forming a coding joint. The inter-
vening DNA is excised and circularized by ligating the blunt DNA
signal ends, thereby forming a signal joint.While multiple of these
episomal recombination excision circles are formed in every devel-
oping B- and T-cell, they seem to have no speciﬁc function. They
are stable products,but cannot replicate in the cell,donot duplicate
during mitosis, and consequently are diluted during cell division,
while the corresponding rearrangement on genomic DNA (cod-
ing joint) is inherited by all daughter cells (Livak and Schatz, 1996;
Breit et al., 1997; van Zelm et al., 2007a). Thus, quantiﬁcation of
coding joints and signal joints from a speciﬁc gene rearrangement
can be used to study cellular turnover and proliferation (van Zelm
et al., 2007a).
GENERATION OF TRECs AND KRECs IN LYMPHOID CELLS
When aB- or T-cell has completed a gene rearrangement and starts
to proliferate, only one of the daughter cells will contain the corre-
sponding excision circle. Thus, it is not possible to study turnover
or proliferation of single cells: each cell either contains a circle or
not. In fact,measurement of turnover or proliferation via excision
circles is performed at the level of a cell population. By comparing
the number of detected signal joints on excision circles to the total
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number of coding joints in the genome, the average proliferation
is established. The condition to detect signal joints at the popu-
lation level requires the need to select a common rearrangement.
However,V(D)J recombination of Ig and TCR loci is optimized to
generate a large repertoire of antigen receptors: in each B- and T-
cell unique combinations of V, D, and J gene segments are formed.
Therefore, most rearrangements are formed to generate a func-
tional B- or T-cell receptor and will consequently not be useful as
targets to study proliferation.
Fortunately, most B- and T-cells initiate a single-step gene
rearrangement to render a speciﬁc locus non-functional. This con-
cerns the δREC–ψJα rearrangement that deletes the entire TCRD
locus in T-cells and the intronRSS–Kde rearrangement that deletes
the constant region of IGK in B-cells (Figure 2). The δREC–ψJα
rearrangement is initiated following unsuccessful generation of a
γδ TcR and is estimated to have occurred on 70–80% of TCRD
alleles in mature αβ+ T-cells (Verschuren et al., 1997). Nearly
all newly formed αβ+ T-cells will have a T-cell receptor excision
circle (TREC) with the δREC–ψJα signal joint (Figure 2A). How-
ever, the coding joint of this rearrangement is not stably present
in the genome. As the TCRD locus is located within the TCRA
locus, subsequent Vα–Jα rearrangements will remove the δREC–
ψJα coding joint from the locus and place it on a novel circular
excision product (Breit et al., 1997; Hazenberg et al., 2000).
In contrast, the intronRSS–Kde rearrangement does gener-
ate a stable coding joint in the IGK locus of B-cells and can-
not be removed by subsequent gene rearrangements, because all
enhancers are removed from the allele (Figure 2B). Moreover, this
rearrangement is one of the last to occur on 35–40% of IGK alleles
prior to migration of B-cells to the periphery and is not followed
by proliferation in bone marrow (van Zelm et al., 2005). Thus,
most B-cells will have a kappa-deletion recombination excision
circle (KREC) with the intronRSS–Kde signal joint. The coding
joint to signal joint ratio of this rearrangement can be used to
quantify B-cell proliferation in secondary lymphoid organs (van
Zelm et al., 2007a). In fact, the intronRSS–Kde fulﬁlls all crite-
ria to be a robust target for replication history studies. (a) it is a
frequently occurring gene rearrangement; (b) it is one of the last
Ig gene rearrangements in bone marrow–derived B cells before
obtaining a functional Ig molecule, ensuring that the correspond-
ing KRECs are abundantly present in naive B lymphocytes; (c) it is
a single-step rearrangement, which allows easy design of RQ-PCR
primers and probes for accurate detection of the coding joints and
signal joints; and (d) it is an end-stage rearrangement, precluding
further rearrangements.
The δREC–ψJα rearrangement fulﬁlls all but the last criterion.
Therefore, the δREC–ψJα TRECs cannot be straightforwardly
used to quantify T-cell proliferation. Still, TREC quantiﬁcation is
suitable formany applications without need for the corresponding
coding joint.
HOW TO QUANTIFY AND INTERPRET RECOMBINATION
EXCISION CIRCLES
V(D)J recombination excision circles are formed by blunt end liga-
tionof signal ends afterRAGcleavage.Thus,a signal joint is formed
between two pieces of DNA that were not in close proximity before
and is an ideal target for a speciﬁc PCR for excision circle detection.
δREC–ψJα TRECs can be reliably detected with TaqMan-based
real-time quantitative (RQ-) PCR (Figure 2; Table 1). For exact
quantiﬁcation, several additional steps need to be undertaken.
First, a standard curve for quantiﬁcation is required. This is com-
monly done on serial dilutions of a signal joint construct cloned in
a bacterial plasmid. Thus, the exact number of TRECs canbe quan-
tiﬁed for a givenDNAsample (TRECs/μgDNA). Furthermore, the
number of TRECs per 106 cells can be estimated based on the the-
oretical recovery of 1μg DNA from approximately 150,000 cells
(Hazenberg et al., 2002; Bains et al., 2009). Alternatively, more
accurate TREC contents can be obtained when quantiﬁcation is
performed relative to a control gene, such as albumin or the TCRA
constant region (Hazenberg et al., 2000; Zubakov et al., 2010).
This would require a parallel RQ-PCR on the same sample and
quantiﬁcation using a dilution series of a bacterial plasmid con-
taining the target gene. Because such a control gene is biallelically
present in the genome, the number of TRECs per 106 cells can be
calculated as follows (Sottini et al., 2010):
Number of TRECs
(Number of control genes)/2
· 106
δREC–ψJα rearrangements are formed in nearly all αβ+ T-cells
and subsequently, most thymic emigrants contain δREC–ψJα
TRECs. Since TRECs cannot replicate, the TREC content is diluted
when T-cells undergo homeostatic or antigen-induced prolifera-
tion. Still, quantiﬁcation of mature T-cell proliferation is compli-
cated, since the exact frequency of TRECs per cell of new thymic
emigrants is unknown. Unfortunately, the δREC–ψJα coding joint
cannot be used asmarker, since it is also removed from the genome
by subsequent Vα–Jα rearrangements (Figure 2). Furthermore,
TREC measurements do not allow direct quantitative statements
on thymic output. TRECs are highly abundant in recent thymic
emigrants, but they are stable structures and they can remain
present in “old” thymic emigrants (Verschuren et al., 1997; Douek
et al., 1998; Hazenberg et al., 2000, 2001; Sodora et al., 2000).
Therefore TRECs are not by deﬁnition markers of recent thymic
emigrants.
Recently, we have introduced the recombination excision cir-
cle of the intronRSS–Kde rearrangement (KREC) to study the
replication history of B-cells (van Zelm et al., 2007a). Since the
intronRSS–Kde rearrangement is one of the last rearrangements to
occur in bone marrow and the coding joint remains stably present
in the genome, it allowed us to reliably quantify cell divisions.
To further enable straightforward quantiﬁcation of proliferation,
we created a cell line that contains one intronRSS–Kde coding
joint and one signal joint per genome. DNA from this cell line,
U698-DB01, can be used to correct for differences in signal joint
and coding joint PCR efﬁciencies. When PCRs are performed on
similar DNA quantities of both the cell line and the samples of
interest, the average number of cell divisions of the sample can be
quantiﬁed as follows:
(
CTsignal joint − CTcoding joint
)
sample
− (CTsignal joint − CTcoding joint
)
cell line
Furthermore, the frequency of B-cells that contain an
intronRSS–Kde coding joint can be determined when a control
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FIGURE 2 |V(D)J recombination and the formation of excision circles.
(A) Sequential rearrangements in theTCRAD locus. Following V(D)J
recombination of TCRD, the whole locus is then preferentially deleted by
δREC–ψJα rearrangements in the αβ+T-cell lineage. This gives rise to a
δREC–ψJα signal joint on an excision circle (TREC) and a δREC–ψJα coding
joint in the genome. The coding joint is deleted from the genome byTCRA
(Vα-Jα) rearrangements and is then located on aTREC as well. (B) V(D)J
recombination on the IGK locus results in a VJκ coding joint. Subsequent
rearrangement between the intronRSS and the Kde elements can render the
IGK allele non-functional by deleting the Cκ exons and the enhancers.
Consequently, the coding joint precludes any further rearrangements in the
IGK locus and therefore remains present in the genome, whereas an
intronRSS–Kde signal joint is formed on an excision circle (KREC).
(C) Oligonucleotide characteristics for TREC, KREC, and control gene
quantiﬁcation (Pongers-Willemse et al., 1998; Hazenberg et al., 2000;
Dik et al., 2005; van Zelm et al., 2007a).
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Table 1 | Application ofTREC and/or KREC analysis in newborn screening to identify immunodeficient patients with various types of genetic
defects that result in extremely low totalT- and/or B-cell numbers.
Disease Genetic defect Analysis References
TREC KREC
SCID IL2RG + − Chan and Puck (2005), Gerstel-Thompson et al. (2010), Morinishi et al. (2009)
IL7RA +* − Gerstel-Thompson et al. (2010)
JAK3 + − Chan and Puck (2005), Hale et al. (2010), Morinishi et al. (2009)
RAG1 + +* Morinishi et al. (2009)
RAG2 +* +*
Artemis (DCLRE1C) +* +*
LIG4 + +* Morinishi et al. (2009)
DNA-PKcs +* +*
ADA + +* Gerstel-Thompson et al. (2010), Morinishi et al. (2009)
PNP + − Gerstel-Thompson et al. (2010)
AK2 +* +*
CD3E +* −
CD3D +* −
CD3G +* −
CD3Z +* −
CD45 +* −
CORO1A +* −
DiGeorge syndrome 22q11.2 deletion + − Routes et al. (2009)
Agammaglobulinemia BTK − + Nakagawa et al. (2011)
IGHM − +*
BLNK − +*
CD79A − +*
CD79B − +*
L14.1 − +*
+, Analysis will yield aberrant result; −, analysis will not reveal aberrancies. ∗Expected based on immunological phenotype of the patient, but not yet demonstrated
in dried blood spots.
gene is quantiﬁed in both the sample and the control cell line. The
frequency of IGK alleles contain the intronRSS–Kde coding joint
can be calculated by:
2
[(
CTcontrol−CTcoding joint
)
sample
−(CTcontrol−CTcoding joint
)
cell line
]
· 100%
The above described approaches for quantiﬁcation of excision
circles are very important to take into account for correct interpre-
tation of the obtained data. Still, in a few settings, straightforward
quantiﬁcation of excision circles with respect to a control gene
can be sufﬁcient to address a speciﬁc question. First, since TRECs
and KRECs are speciﬁcally formed in developing lymphocytes,
they can be used to determine the presence of T- and B-cells,
respectively. This has been exploited in recent years to develop
newborn screening tests for SCID and agammaglobulinemia (see
below). Furthermore, very recent studies demonstrated a lin-
ear correlation between the frequency of TRECs in blood with
human individual age (Zubakov et al., 2010). These analyses only
require the difference in CT value of the TREC signal joint PCR
as compared with the CT value of the control gene PCR (Zubakov
et al., 2010). The strong linear decline in TRECs with age is very
intriguing. Since TRECs were determined from full blood, the
decrease is likely to result from both a decrease in blood T-cell
numbers in young children and increased proliferation of mature
T-cells in later childhood and adulthood (Comans-Bitter et al.,
1997). The TREC decline in an aging immune system in normal
individuals can be used as a reference for studies on premature
or early immunosenescence under particular disease conditions
(Betjes et al., 2011). Interestingly, the decline in KRECs was much
less pronounced (Menno C. van Zelm, unpublished observa-
tions). A potential explanation is the more stable generation of
new B-cells from bone marrow in older individuals as compared
with new T-cell from thymus. Thus, the KREC content remains
much higher since the dilution from additional proliferation
is limited.
NEWBORN SCREENING OF SCID AND
AGAMMAGLOBULINEMIA
Early diagnosis is critical for patients suffering fromPID to prevent
irreversible organ damage or early death. This is especially true for
SCID patients, in whom infections become quickly fatal in the ﬁrst
months of life. Ideally, patients should be identiﬁed in a newborn
screening protocol prior to developing disease symptoms to allow
successful stem cell replacement therapy (Buckley, 2004; Puck,
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2007). This would require a straightforward screening method
that can be applied on dried heel-stick blood spots on Guthrie
cards from neonates.
In 2005, Chan and Puck (2005) introduced a newborn
screening method based on RQ-PCR detection of δREC–ψJα
TRECs. This method proved to be very reliable in detecting
T-cells in healthy neonates. Furthermore, TRECs were consis-
tently very low to absent in blood from SCID patients suffer-
ing from various gene defects Table 1; Chan and Puck, 2005;
Morinishi et al., 2009; Routes et al., 2009; Gerstel-Thompson
et al., 2010; Hale et al., 2010). Based on these promising results,
state-wide newborn screening is implemented in Wisconsin and
assay validation has started in Massachusetts (Routes et al., 2009;
Gerstel-Thompson et al., 2010).
Besides the easy detection with RQ-PCR and the speciﬁc gener-
ation of TRECs in developingT-cells, the success of SCIDnewborn
screening with TRECs beneﬁted from the additional phenomena
of TREC dilution in adults. Young children have high TREC num-
bers, which provide a good signal to noise ratio. Furthermore, the
presence of maternal T-cells or residual T-cells in “leaky” SCID
patients thus hardly affects TREC numbers due to their extensive
replication history.
Analogous to SCID, efforts have been initiated to set-up KREC-
based screening for B-cell maturation defects (Nakagawa et al.,
2011). These initial results revealed the presence of >200 KREC
copies/μg DNA in healthy children, whereas no KRECs were
detected in 30 XLA patients and 5 non-BTK agammaglobulinemia
patients.
RECENT INSIGHTS AND NEW DIRECTIONS FOR ANALYSIS OF
TRECs AND KRECs IN PID
HEMATOPOIETIC STEM CELL TREATMENT EVALUATION
The only corrective treatment for patients with PID used to be
hematopoietic stem cell replacement therapies. Stem cell replace-
ment therapy is the ﬁrst treatment choice for patients with a severe
T-cell defect. Over the past decades, enormous advances have been
made with stem cell transplantation and the success rate is very
high in young patients andwith good donormatches. Still, the lim-
ited availability of properly matched donors requires the need for
alternatives. Supported by the advances in molecular diagnostics
of PID, gene therapy protocols have been developed, in which the
patients’ own hematopoietic stem cells are corrected with a wild
type copy of the defective gene (“gene therapy”). Despite setbacks
due to adverse insertional mutagenesis (Hacein-Bey-Abina et al.,
2003), many gene therapy protocols have been restarted in the last
years (Aiuti et al., 2009).
Quantiﬁcation of δREC–ψJα TRECs has been informative for
assessment of thymic T-cell neogenesis (Douek et al., 1998;Hazen-
berg et al., 2000). Initial insights have been obtained from HIV
patients, in whom a low TREC content was demonstrated that
could be reverted upon antiretroviral treatment (Douek et al.,
1998; Lewin et al., 2002; Di Mascio et al., 2006). Furthermore,
low TREC levels following hematopoietic stem cell transplanta-
tion have been shown to correlate with clinical morbidity and
mortality from infection (Douek et al., 2000; Hazenberg et al.,
2002; Lewin et al., 2002; Brown et al., 2010).
Recently, B- and T-cell recovery of PID patients following stem
cell transplantation have been studied in a multiplex setting for
KREC and TREC detection (Sottini et al., 2010). Such evaluations
can be very informative to obtain early insight into B- and T-
cell neogenesis, and a valuable addition to ﬂow cytometric and
donor/acceptor chimerism analysis.
CLASSIFICATION OF CVID PATIENTS
Despite recent advances in genetics of PID, in many PID patients
no molecular diagnosis is made. The number of patients with a
humoral immunodeﬁciency without molecular diagnosis is espe-
cially high.Most of these patients are diagnosed as having common
variable immunodeﬁciency (CVID). As apparent from the name,
these patients have a highly diverse clinical phenotype, likely
in part resulting from genetic variation. In the past decade the
“Freiburg” and “Paris” CVID classiﬁcations have been developed
based on the composition of the peripheral B-cell compartment
(Warnatz et al., 2002; Piqueras et al., 2003). Several patient sub-
groups display distinct abnormalities in B-cell subsets of which the
cause remains unknown. Quantiﬁcation of the replication history
(with KRECs) of sorted B-cell subsets on top of ﬂow cytometric
analysis could help to explain aberrancies in the B-cell compart-
ments of these patients. In absence of a molecular analysis, such
immunological parameters will be important to deﬁne subgroups
of patients and prediction of future complications.
STUDIES ON NORMAL AND ABERRANT LYMPHOID MATURATION
Memory B cells in blood have been classically divided into
CD27+IgD+ and CD27+IgD− subsets. The presence of
CD27+IgD+ cells in patients with CD40L deﬁciency who lack
functional germinal centers has lead to the conclusion that these
can be generated independently of T cell help (Agematsu et al.,
1998;Weller et al., 2001, 2004). Furthermore, they strongly resem-
ble splenic marginal zone B cells (Weller et al., 2004). However,
these conclusions have been challenged by the facts that natural
effector cells showed molecular footprints of the GC reaction
and that similar IGH gene rearrangements were found in natural
effector B cells and in CD27+IgG+ B cells (Seifert and Kuppers,
2009). Furthermore, the absolute numbers of CD27+IgD+ B cells
are clearly reduced in CD40L-deﬁcient patients (Agematsu et al.,
1998; Weller et al., 2001, 2004). Thus, this B-cell subset in healthy
individuals is likely to be a mixed population of GC-derived and
splenic marginal zone-derived “natural effector” memory B cells.
By using the intronRSS–Kde coding joint / signal joint ratio, we
quantiﬁed homeostatic and antigen-induced B-cell proliferation
in puriﬁed B-cell subsets of healthy individuals (van Zelm et al.,
2007a,b). The replication history of CD27+IgD+ B-cells was con-
sistently lower than CD27+IgD− B-cells, both in childhood tonsil
(4 vs 8 cell cycles) and in adult blood (6 vs 11 cell cycles; van
Zelm et al., 2007a). Interestingly, germinal center B cells from
childhood tonsil already had a replication history of eight cell
cycles (van Zelm et al., 2007a). The replication history of the
total subset of CD27+IgD+ B cells was clearly less than B cells
undergoing a T-cell dependent response in the germinal center
and supports the idea that at least part of the CD27+IgD+ B
cells are derived from T-cell dependent responses (Weller et al.,
2001). Thus, the use of KRECs to quantify the replication history
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can be of added value to identify the origin and maturation
pathways of memory B cells. This is especially interesting, since
CD27+IgD− memory B cells are in fact a mixture of IgM-only,
IgG+ and IgA+ B cells. Furthermore, recent studies have iden-
tiﬁed CD27−IgA+ and CD27−IgG+ memory B cells (Fecteau
et al., 2006; Wei et al., 2007; Cagigi et al., 2009). Quantiﬁcation of
their replication history in combinationwith additionalmolecular
and phenotypic analysis could help to delineate their origin and
maturation pathways.
The replication history of normal B-cell subsets has pro-
vided a template for analysis of the aberrant population in B-
cells of patients with immunological disease (Moir et al., 2008;
Rakhmanov et al., 2009; van der Burg et al., 2010). Interest-
ingly, both in patients suffering from HIV and in a subgroup
of CVID patients, an expanded CD21low B-cell population has
been observed (Warnatz et al., 2002; Moir et al., 2008). These
cells showed a replication history of ∼4 cell cycles, which was
increased as compared with naive mature B-cells (two divi-
sions), but decreased as compared with memory B-cells (6–10
cell cycles). It is currently debated whether these cells are naive
anergic B-cells or tissue-like memory-B cells (Moir et al., 2008;
Isnardi et al., 2010; Rakhmanov et al., 2009). Further analy-
sis of CD27 and Ig isotype expression could help to resolve
this discussion.
Recently, we analyzed the replication history of B-cells in
patients with Nijmegen breakage syndrome (NBS; repair syn-
drome; van der Burg et al., 2010). NBS patients have a DNA repair
defect and reduced B- and T-cell numbers resulting from inef-
ﬁcient V(D)J recombination. Still, both coding joints and signal
joints can be robustly formed in absence of functional NBN pro-
tein and show normal characteristics (Saidi et al., 2010; van der
Burg et al., 2010). Interestingly, the replication history of NBS
patients’ naive mature B-cells was ∼4 cell cycles, which was sim-
ilar to the CD21low B-cells in HIV and CVID patients that were
described above. The increased proliferation in NBS most likely
resulted fromdecreased output of newB-cell emigrants frombone
marrow and increased homeostatic proliferation to compensate
the total peripheral B-cell number (van der Burg et al., 2010). The
decreased KREC levels thus reﬂect a form of premature senescence
of the immune system in NBS patients.
The above described observations clearly illustrate how KRECs
can be used to support studies on the B-cell compartment of
patients suffering from a PID. Unfortunately, analogous analy-
sis of the T-cell compartment is hampered by the lack of a
good internal control for quantiﬁcation with δREC–ψJα TRECs.
The corresponding coding joint is removed from the genome by
subsequent Vα–Jα rearrangements. Therefore, it remains unclear
how many TRECs are formed in thymus. Furthermore, following
δREC–ψJα rearrangements, thymocytes undergo several roundsof
proliferation. Still, these disadvantages as compared to the B-cell
compartment can be overcome. First, the frequency of δREC–ψJα
coding joints and signal joints can be quantiﬁed in thymocyte sub-
sets and the proliferation in thymus can be calculated for CD4+
and CD8+ single positive thymocytes. Based on these data, the
TREC frequencies in peripheral T-cell subsets can be corrected to
calculate peripheral T-cell proliferation (K. van der Weerd et al.
submitted for publication). Additionally, TRECs from other TCR
rearrangements can be used to calculate T-cell proliferation. These
would have to be single-step rearrangements, relatively frequent,
and the coding joint should remain stably present in the genome.
We are currently evaluating the potential of such TRECs in other
TCR loci.
NEWBORN SCREENING FOR SCID AND AGAMMAGLOBULINEMIA
With the introduction of TRECs to detect patients with SCID,
all major criteria were met for inclusion in newborn screening
protocols. The estimated incidence of SCID is >1:100,000 live
births (Chan and Puck, 2005) and life-saving therapies exist. Fur-
thermore, it has become clear that early diagnosis and early treat-
ment initiation increases successful outcome rates. Using RQ-PCR
techniques, the absence of blood T-cells can be robustly deter-
mined from DNA of dried blood spots. It should be possible to
detect all SCID patients, independently of the underlying genetic
defect. This is supported by multiple studies in which patients
with various identiﬁed and unidentiﬁed genetic defects have been
detected (Table 1).
The successful detection of agammaglobulinemia patients with
KRECs now opens the way to inclusion of this technique for detec-
tion of agammaglobulinemia in newborn screening. The clinical
phenotype of agammaglobulinemia is milder than SCID. Still, the
disease is underdiagnosed in the ﬁrst years of life and patients can
develop serious organ damage before a diagnosis of immunod-
eﬁciency has been made. Thus, early identiﬁcation by newborn
screening can contribute to quality of life and reduction of health
care costs.
Finally, RQ-PCR-based newborn screening has the advantage
that tests canbe combined in amultiplex setting.This has been suc-
cessfully tested for detectionof TRECs and an internal control gene
(Gerstel-Thompson et al., 2010). Theoretically, it would be possi-
ble to also includeKRECdetection in this assay. Thus, a single assay
could be developed to screen for both agammaglobulinemia and
SCID with a combined estimated incidence of 1:30,000–1:50,000
births. Furthermore, T-cell deﬁcient cases can be further separated
inB-cell positive andB-cell negative subgroups, guiding additional
diagnostics toward either T−B+ or T−B− SCID (Table 1). Con-
sequently, such a combined test should keep the costs low, while
increasing thebeneﬁtswith regard todisease incidence andguiding
of further diagnostics.
In conclusion, we here provide an overview of how V(D)J
recombination excision circles can be used to obtain insights
into the normal and aberrant lymphoid immune system. We
are convinced that KREC and TREC analysis in combination
with ﬂow cytometric evaluation of T- and B-cell subpopula-
tions of PID patients will provide new insights into their dis-
ease and may contribute to the identiﬁcation of new genetic
defects. Especially, combined quantiﬁcation of TRECs and KRECs
could support early diagnosis in newborn screening proto-
cols, patient subgroup classiﬁcation and evaluation of stem cell
replacement therapy.
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